

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.50513920 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.50513920 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.39570590 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.39570590 |
| 5 | lysine catabolic process (GO:0006554) | 6.14466691 |
| 6 | lysine metabolic process (GO:0006553) | 6.14466691 |
| 7 | glyoxylate metabolic process (GO:0046487) | 5.74481990 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.63781110 |
| 9 | cysteine metabolic process (GO:0006534) | 5.37337703 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.26378279 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.24514655 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 5.17967924 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.09191297 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.98732027 |
| 15 | amino-acid betaine metabolic process (GO:0006577) | 4.91867777 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.90211881 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.90211881 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.90211881 |
| 19 | bile acid biosynthetic process (GO:0006699) | 4.84665327 |
| 20 | fatty acid beta-oxidation (GO:0006635) | 4.77879685 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.77850130 |
| 22 | 2-oxoglutarate metabolic process (GO:0006103) | 4.75525197 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 4.72746381 |
| 24 | short-chain fatty acid metabolic process (GO:0046459) | 4.67858796 |
| 25 | urea metabolic process (GO:0019627) | 4.67425165 |
| 26 | urea cycle (GO:0000050) | 4.67425165 |
| 27 | tryptophan metabolic process (GO:0006568) | 4.67341579 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.62497530 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 4.59525282 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.58066313 |
| 31 | valine metabolic process (GO:0006573) | 4.52968771 |
| 32 | cellular ketone body metabolic process (GO:0046950) | 4.49866182 |
| 33 | fatty acid oxidation (GO:0019395) | 4.46809114 |
| 34 | acetyl-CoA metabolic process (GO:0006084) | 4.46470673 |
| 35 | fatty acid catabolic process (GO:0009062) | 4.37205465 |
| 36 | lipid oxidation (GO:0034440) | 4.37169495 |
| 37 | alpha-amino acid catabolic process (GO:1901606) | 4.35386782 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.35178821 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 4.33004097 |
| 40 | ethanol oxidation (GO:0006069) | 4.27221754 |
| 41 | high-density lipoprotein particle remodeling (GO:0034375) | 4.25952455 |
| 42 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.25534530 |
| 43 | carnitine metabolic process (GO:0009437) | 4.23431362 |
| 44 | monocarboxylic acid catabolic process (GO:0072329) | 4.19886748 |
| 45 | tricarboxylic acid metabolic process (GO:0072350) | 4.18741094 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 4.16786202 |
| 47 | cellular amino acid catabolic process (GO:0009063) | 4.16282123 |
| 48 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.09810582 |
| 49 | bile acid metabolic process (GO:0008206) | 4.05754086 |
| 50 | cellular modified amino acid catabolic process (GO:0042219) | 4.03238511 |
| 51 | negative regulation of fibrinolysis (GO:0051918) | 4.01615926 |
| 52 | regulation of gamma-delta T cell activation (GO:0046643) | 4.00581022 |
| 53 | serine family amino acid metabolic process (GO:0009069) | 4.00519764 |
| 54 | branched-chain amino acid catabolic process (GO:0009083) | 3.99974282 |
| 55 | biotin metabolic process (GO:0006768) | 3.98018484 |
| 56 | tyrosine metabolic process (GO:0006570) | 3.97115776 |
| 57 | * organic acid catabolic process (GO:0016054) | 3.96722636 |
| 58 | * carboxylic acid catabolic process (GO:0046395) | 3.96722636 |
| 59 | triglyceride homeostasis (GO:0070328) | 3.95700814 |
| 60 | acylglycerol homeostasis (GO:0055090) | 3.95700814 |
| 61 | glutamate metabolic process (GO:0006536) | 3.94096905 |
| 62 | branched-chain amino acid metabolic process (GO:0009081) | 3.93729854 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 3.92742992 |
| 64 | glycine metabolic process (GO:0006544) | 3.91411711 |
| 65 | NADH metabolic process (GO:0006734) | 3.90566586 |
| 66 | ketone body metabolic process (GO:1902224) | 3.88931176 |
| 67 | coenzyme catabolic process (GO:0009109) | 3.88699840 |
| 68 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.88228116 |
| 69 | regulation of cholesterol homeostasis (GO:2000188) | 3.87613786 |
| 70 | complement activation, alternative pathway (GO:0006957) | 3.87046860 |
| 71 | drug transmembrane transport (GO:0006855) | 3.86146527 |
| 72 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.86043278 |
| 73 | protein carboxylation (GO:0018214) | 3.86043278 |
| 74 | tricarboxylic acid cycle (GO:0006099) | 3.84241468 |
| 75 | oxaloacetate metabolic process (GO:0006107) | 3.83392018 |
| 76 | fatty acid transmembrane transport (GO:1902001) | 3.80992788 |
| 77 | positive thymic T cell selection (GO:0045059) | 3.78610467 |
| 78 | reverse cholesterol transport (GO:0043691) | 3.76828544 |
| 79 | drug catabolic process (GO:0042737) | 3.76107844 |
| 80 | positive regulation of granulocyte differentiation (GO:0030854) | 3.75003358 |
| 81 | regulation of protein activation cascade (GO:2000257) | 3.74977620 |
| 82 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74723809 |
| 83 | negative regulation of sterol transport (GO:0032372) | 3.71798464 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 3.71798464 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 3.71286238 |
| 86 | regulation of cholesterol esterification (GO:0010872) | 3.70280302 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.69278041 |
| 88 | positive regulation of fatty acid oxidation (GO:0046321) | 3.67665109 |
| 89 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.66124679 |
| 90 | regulation of fibrinolysis (GO:0051917) | 3.64756060 |
| 91 | carnitine shuttle (GO:0006853) | 3.64633181 |
| 92 | plasma lipoprotein particle remodeling (GO:0034369) | 3.63733053 |
| 93 | protein-lipid complex remodeling (GO:0034368) | 3.63733053 |
| 94 | macromolecular complex remodeling (GO:0034367) | 3.63733053 |
| 95 | cellular response to exogenous dsRNA (GO:0071360) | 3.63406276 |
| 96 | plasma lipoprotein particle clearance (GO:0034381) | 3.62810895 |
| 97 | negative thymic T cell selection (GO:0045060) | 3.59570410 |
| 98 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.57243828 |
| 99 | negative T cell selection (GO:0043383) | 3.54619307 |
| 100 | urate metabolic process (GO:0046415) | 3.54569811 |
| 101 | regulation of complement activation (GO:0030449) | 3.50795172 |
| 102 | regulation of sequestering of triglyceride (GO:0010889) | 3.50593911 |
| 103 | positive T cell selection (GO:0043368) | 3.50022662 |
| 104 | succinate metabolic process (GO:0006105) | 3.49027482 |
| 105 | phospholipid efflux (GO:0033700) | 3.48587439 |
| 106 | regulation of fatty acid oxidation (GO:0046320) | 3.48044057 |
| 107 | indolalkylamine metabolic process (GO:0006586) | 3.47963134 |
| 108 | benzene-containing compound metabolic process (GO:0042537) | 3.47891193 |
| 109 | phospholipid homeostasis (GO:0055091) | 3.38463209 |
| 110 | flavonoid metabolic process (GO:0009812) | 3.37581175 |
| 111 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.36258370 |
| 112 | aldehyde catabolic process (GO:0046185) | 3.35095714 |
| 113 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.34240378 |
| 114 | Peyers patch development (GO:0048541) | 3.33537609 |
| 115 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.33537609 |
| 116 | amino-acid betaine transport (GO:0015838) | 3.32840904 |
| 117 | positive regulation of B cell differentiation (GO:0045579) | 3.29310054 |
| 118 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.25003890 |
| 119 | cellular response to ATP (GO:0071318) | 3.23173315 |
| 120 | T cell selection (GO:0045058) | 3.15595182 |
| 121 | positive regulation of defense response to virus by host (GO:0002230) | 3.11846843 |
| 122 | thymic T cell selection (GO:0045061) | 3.10622891 |
| 123 | NAD biosynthetic process (GO:0009435) | 3.07823279 |
| 124 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05087834 |
| 125 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01087550 |
| 126 | regulation of B cell differentiation (GO:0045577) | 3.00946632 |
| 127 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.97647512 |
| 128 | regulation of granulocyte differentiation (GO:0030852) | 2.94058757 |
| 129 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.93004074 |
| 130 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.92698955 |
| 131 | mature B cell differentiation (GO:0002335) | 2.91080025 |
| 132 | immunoglobulin mediated immune response (GO:0016064) | 2.90915312 |
| 133 | protein K48-linked deubiquitination (GO:0071108) | 2.90632996 |
| 134 | histone H3-K4 trimethylation (GO:0080182) | 2.90105036 |
| 135 | DNA deamination (GO:0045006) | 2.89408295 |
| 136 | mannose metabolic process (GO:0006013) | 2.88856352 |
| 137 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.85805419 |
| 138 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.84705021 |
| 139 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.81434139 |
| 140 | histone H3-K9 modification (GO:0061647) | 2.80431656 |
| 141 | mature B cell differentiation involved in immune response (GO:0002313) | 2.76625637 |
| 142 | histone H3-K9 methylation (GO:0051567) | 2.75949734 |
| 143 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.74090241 |
| 144 | snRNA transcription (GO:0009301) | 2.72725213 |
| 145 | positive regulation of developmental pigmentation (GO:0048087) | 2.70696614 |
| 146 | positive regulation of antigen processing and presentation (GO:0002579) | 2.66367031 |
| 147 | fucose catabolic process (GO:0019317) | 2.64744052 |
| 148 | L-fucose metabolic process (GO:0042354) | 2.64744052 |
| 149 | L-fucose catabolic process (GO:0042355) | 2.64744052 |
| 150 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.64557008 |
| 151 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.63404581 |
| 152 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.62336500 |
| 153 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.61747825 |
| 154 | regulation of germinal center formation (GO:0002634) | 2.58209343 |
| 155 | interkinetic nuclear migration (GO:0022027) | 2.56413106 |
| 156 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.55303140 |
| 157 | positive regulation of protein deacetylation (GO:0090312) | 2.53887007 |
| 158 | tolerance induction (GO:0002507) | 2.52782842 |
| 159 | behavioral response to nicotine (GO:0035095) | 2.51658105 |
| 160 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.50688835 |
| 161 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.49816923 |
| 162 | negative regulation of cell killing (GO:0031342) | 2.49816923 |
| 163 | positive regulation of fatty acid transport (GO:2000193) | 2.48379408 |
| 164 | regulation of antigen processing and presentation (GO:0002577) | 2.47396567 |
| 165 | regulation of defense response to virus by host (GO:0050691) | 2.47134558 |
| 166 | sulfation (GO:0051923) | 2.46865089 |
| 167 | positive regulation of histone deacetylation (GO:0031065) | 2.44752743 |
| 168 | response to protozoan (GO:0001562) | 2.43371584 |
| 169 | cytokine biosynthetic process (GO:0042089) | 2.43340725 |
| 170 | hepatocyte apoptotic process (GO:0097284) | 2.43013225 |
| 171 | cellular biogenic amine catabolic process (GO:0042402) | 2.42977586 |
| 172 | amine catabolic process (GO:0009310) | 2.42977586 |
| 173 | positive regulation of icosanoid secretion (GO:0032305) | 2.42349408 |
| 174 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.42015484 |
| 175 | germinal center formation (GO:0002467) | 2.41661157 |
| 176 | cardiolipin metabolic process (GO:0032048) | 2.41031491 |
| 177 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.40968498 |
| 178 | detection of light stimulus involved in visual perception (GO:0050908) | 2.40968498 |
| 179 | interferon-gamma production (GO:0032609) | 2.40948791 |
| 180 | defense response to protozoan (GO:0042832) | 2.40850950 |
| 181 | regulation of hippo signaling (GO:0035330) | 2.38229092 |
| 182 | mast cell activation (GO:0045576) | 2.37976133 |
| 183 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.37870194 |
| 184 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.37870194 |
| 185 | cellular response to ethanol (GO:0071361) | 2.37116221 |
| 186 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.32402808 |
| 187 | response to type I interferon (GO:0034340) | 2.30467905 |
| 188 | cellular response to interleukin-15 (GO:0071350) | 2.28846925 |
| 189 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.28098279 |
| 190 | response to interleukin-15 (GO:0070672) | 2.27049540 |
| 191 | B cell homeostasis (GO:0001782) | 2.25742500 |
| 192 | negative regulation of granulocyte differentiation (GO:0030853) | 2.25653318 |
| 193 | peptidyl-lysine methylation (GO:0018022) | 2.22842292 |
| 194 | indole-containing compound metabolic process (GO:0042430) | 2.22816369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.31070173 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.20852765 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.40168792 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.37724414 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.69940424 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.47484762 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.02046829 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.59869093 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.56136978 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.27957908 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.16465151 |
| 12 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.12799823 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.41658180 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.32558403 |
| 15 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25484320 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.21892162 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.21712404 |
| 18 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.17599474 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.10000346 |
| 20 | * MYB_26560356_Chip-Seq_TH2_Human | 2.02960049 |
| 21 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.02161476 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01006253 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00305011 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1728654 |
| 25 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.93166752 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.92287772 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.91236435 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89944616 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.89415391 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86026629 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.79617815 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.79067755 |
| 33 | MAF_26560356_Chip-Seq_TH2_Human | 1.75576688 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.75070219 |
| 35 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.73859110 |
| 36 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.73785832 |
| 37 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.72581981 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.70096229 |
| 39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.65956300 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65344084 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63649465 |
| 42 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.58313568 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54445732 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51416899 |
| 45 | GATA3_26560356_Chip-Seq_TH2_Human | 1.51070999 |
| 46 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47446243 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44630803 |
| 48 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.42265546 |
| 49 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41996410 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41527323 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41386106 |
| 52 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.40863254 |
| 53 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.37022722 |
| 54 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34696449 |
| 55 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33509885 |
| 56 | ERA_21632823_ChIP-Seq_H3396_Human | 1.32854365 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32746767 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32530997 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30740002 |
| 60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29256422 |
| 61 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26281557 |
| 62 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25615628 |
| 63 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22347890 |
| 64 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21607746 |
| 65 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.21143567 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20924296 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18809057 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18461827 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.18383124 |
| 70 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.17886402 |
| 71 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17371293 |
| 72 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16147025 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14764319 |
| 74 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14730512 |
| 75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.14472179 |
| 76 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.13457523 |
| 77 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.10587454 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10299318 |
| 79 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08148569 |
| 80 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08060403 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07086010 |
| 82 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.06928340 |
| 83 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05940431 |
| 84 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05743716 |
| 85 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03899148 |
| 86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02926108 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02604574 |
| 88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02278605 |
| 89 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01972084 |
| 90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.01963267 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01789934 |
| 92 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01740343 |
| 93 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01126717 |
| 94 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97869045 |
| 95 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.97712668 |
| 96 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96862360 |
| 97 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.95980178 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95067405 |
| 99 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.94274938 |
| 100 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.93676953 |
| 101 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93552945 |
| 102 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93448604 |
| 103 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92919968 |
| 104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92874262 |
| 105 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92870923 |
| 106 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92443374 |
| 107 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.91897409 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91075550 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90970815 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89902266 |
| 111 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87656649 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87349964 |
| 113 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.85086886 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84768432 |
| 115 | P68_20966046_ChIP-Seq_HELA_Human | 0.83515617 |
| 116 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.83301951 |
| 117 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.82216326 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81477167 |
| 119 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80560581 |
| 120 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.80229914 |
| 121 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.78775075 |
| 122 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78771202 |
| 123 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77773744 |
| 124 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77592818 |
| 125 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76263098 |
| 126 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.76135408 |
| 127 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75726497 |
| 128 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75317342 |
| 129 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.75317342 |
| 130 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.73640429 |
| 131 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.73144057 |
| 132 | * MYC_22102868_ChIP-Seq_BL_Human | 0.72005142 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69524353 |
| 134 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66814797 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.66162713 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.66059770 |
| 137 | ATF3_27146783_Chip-Seq_COLON_Human | 0.65886457 |
| 138 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.65845869 |
| 139 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65391300 |
| 140 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.64627889 |
| 141 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.64287278 |
| 142 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.64283273 |
| 143 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.64090079 |
| 144 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.62885127 |
| 145 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.62719741 |
| 146 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.62129518 |
| 147 | P300_27268052_Chip-Seq_Bcells_Human | 0.61873000 |
| 148 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.61388549 |
| 149 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.60509941 |
| 150 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60458562 |
| 151 | SA1_27219007_Chip-Seq_Bcells_Human | 0.60152454 |
| 152 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.60078682 |
| 153 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.59981315 |
| 154 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.59960732 |
| 155 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59297299 |
| 156 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.58840733 |
| 157 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.58498355 |
| 158 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.56699801 |
| 159 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.55995276 |
| 160 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.55542067 |
| 161 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55178907 |
| 162 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54907880 |
| 163 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.54803938 |
| 164 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.54505623 |
| 165 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.54224192 |
| 166 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53684126 |
| 167 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.53427169 |
| 168 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.52968509 |
| 169 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.52966504 |
| 170 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.52849719 |
| 171 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.52624626 |
| 172 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.52624349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.44624850 |
| 2 | MP0005360_urolithiasis | 6.99729233 |
| 3 | MP0005365_abnormal_bile_salt | 5.62518478 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.30765975 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.28903125 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.00140633 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.40056072 |
| 8 | MP0003252_abnormal_bile_duct | 3.29087442 |
| 9 | MP0009840_abnormal_foam_cell | 3.16233253 |
| 10 | MP0005332_abnormal_amino_acid | 3.11536757 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.81268436 |
| 12 | MP0001800_abnormal_humoral_immune | 2.76599834 |
| 13 | MP0005083_abnormal_biliary_tract | 2.75266173 |
| 14 | MP0000685_abnormal_immune_system | 2.69157565 |
| 15 | MP0005671_abnormal_response_to | 2.67876509 |
| 16 | MP0003195_calcinosis | 2.65920989 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.62853433 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.59814937 |
| 19 | MP0005670_abnormal_white_adipose | 2.41363181 |
| 20 | MP0003436_decreased_susceptibility_to | 2.28768191 |
| 21 | MP0005387_immune_system_phenotype | 2.26965347 |
| 22 | MP0001790_abnormal_immune_system | 2.26965347 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.23172540 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.22612123 |
| 25 | MP0002837_dystrophic_cardiac_calcinosis | 2.19383806 |
| 26 | MP0001986_abnormal_taste_sensitivity | 2.19319102 |
| 27 | MP0008057_abnormal_DNA_replication | 2.18423694 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 2.11994161 |
| 29 | MP0009278_abnormal_bone_marrow | 2.11632080 |
| 30 | MP0000609_abnormal_liver_physiology | 2.10284640 |
| 31 | MP0005174_abnormal_tail_pigmentation | 2.09576567 |
| 32 | MP0002723_abnormal_immune_serum | 2.09446820 |
| 33 | MP0002452_abnormal_antigen_presenting | 2.05961402 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.99975511 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.97789215 |
| 36 | MP0001819_abnormal_immune_cell | 1.97180438 |
| 37 | MP0003724_increased_susceptibility_to | 1.96238918 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.94944884 |
| 39 | MP0005310_abnormal_salivary_gland | 1.94055289 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.91959727 |
| 41 | MP0001873_stomach_inflammation | 1.88254120 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.87087128 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.87080050 |
| 44 | MP0005025_abnormal_response_to | 1.87009788 |
| 45 | MP0002398_abnormal_bone_marrow | 1.81847456 |
| 46 | MP0004130_abnormal_muscle_cell | 1.80602939 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.79598403 |
| 48 | MP0004381_abnormal_hair_follicle | 1.77892427 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.76335406 |
| 50 | MP0003866_abnormal_defecation | 1.76031681 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.75223580 |
| 52 | MP0000716_abnormal_immune_system | 1.71223986 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.67243838 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.65820021 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.64911221 |
| 56 | MP0002419_abnormal_innate_immunity | 1.60580676 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.59396580 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.58534014 |
| 59 | MP0003868_abnormal_feces_composition | 1.57925409 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.57326777 |
| 61 | MP0001764_abnormal_homeostasis | 1.57263198 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.56805905 |
| 63 | MP0003045_fibrosis | 1.54370281 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.54076612 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.48173086 |
| 66 | MP0002405_respiratory_system_inflammati | 1.47848376 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.47148045 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.47148045 |
| 69 | MP0003303_peritoneal_inflammation | 1.45861864 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.44747127 |
| 71 | MP0002722_abnormal_immune_system | 1.42010810 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.41554239 |
| 73 | MP0002429_abnormal_blood_cell | 1.39234043 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.36603769 |
| 75 | MP0001968_abnormal_touch/_nociception | 1.32279713 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 1.31979142 |
| 77 | MP0004043_abnormal_pH_regulation | 1.31059659 |
| 78 | MP0003186_abnormal_redox_activity | 1.30849871 |
| 79 | MP0009785_altered_susceptibility_to | 1.30832174 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 1.29905200 |
| 81 | MP0002971_abnormal_brown_adipose | 1.27979301 |
| 82 | MP0005535_abnormal_body_temperature | 1.27468734 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.17235814 |
| 84 | MP0001756_abnormal_urination | 1.16865948 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 1.12936331 |
| 86 | MP0000598_abnormal_liver_morphology | 1.12630306 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 1.12293708 |
| 88 | MP0005464_abnormal_platelet_physiology | 1.08676439 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 1.06484578 |
| 90 | MP0005551_abnormal_eye_electrophysiolog | 1.06029158 |
| 91 | MP0003646_muscle_fatigue | 1.04719093 |
| 92 | MP0004808_abnormal_hematopoietic_stem | 1.02327892 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 1.00272855 |
| 94 | MP0005334_abnormal_fat_pad | 1.00220991 |
| 95 | MP0003787_abnormal_imprinting | 0.97867586 |
| 96 | MP0002653_abnormal_ependyma_morphology | 0.97613209 |
| 97 | MP0000371_diluted_coat_color | 0.97590382 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.97254387 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.97179831 |
| 100 | MP0009697_abnormal_copulation | 0.96718943 |
| 101 | MP0002933_joint_inflammation | 0.96456959 |
| 102 | MP0005266_abnormal_metabolism | 0.95989561 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.94684061 |
| 104 | MP0005451_abnormal_body_composition | 0.94259667 |
| 105 | MP0000604_amyloidosis | 0.91294539 |
| 106 | MP0001664_abnormal_digestion | 0.90966528 |
| 107 | MP0003329_amyloid_beta_deposits | 0.90230275 |
| 108 | MP0008877_abnormal_DNA_methylation | 0.89345043 |
| 109 | MP0005448_abnormal_energy_balance | 0.87220376 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.85996741 |
| 111 | MP0006082_CNS_inflammation | 0.85719261 |
| 112 | MP0005330_cardiomyopathy | 0.85181041 |
| 113 | MP0005084_abnormal_gallbladder_morpholo | 0.84340783 |
| 114 | MP0002970_abnormal_white_adipose | 0.82184312 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.81333406 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.81187459 |
| 117 | MP0002019_abnormal_tumor_incidence | 0.80507757 |
| 118 | MP0000538_abnormal_urinary_bladder | 0.76895103 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.76328606 |
| 120 | MP0005646_abnormal_pituitary_gland | 0.76256478 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.76186379 |
| 122 | MP0005377_hearing/vestibular/ear_phenot | 0.75859832 |
| 123 | MP0003878_abnormal_ear_physiology | 0.75859832 |
| 124 | MP0001663_abnormal_digestive_system | 0.75629269 |
| 125 | MP0008469_abnormal_protein_level | 0.75369611 |
| 126 | MP0004947_skin_inflammation | 0.74890891 |
| 127 | MP0009763_increased_sensitivity_to | 0.74872619 |
| 128 | MP0004185_abnormal_adipocyte_glucose | 0.74738686 |
| 129 | MP0003953_abnormal_hormone_level | 0.73043411 |
| 130 | MP0000470_abnormal_stomach_morphology | 0.72114412 |
| 131 | MP0002909_abnormal_adrenal_gland | 0.72050345 |
| 132 | MP0002876_abnormal_thyroid_physiology | 0.71793940 |
| 133 | MP0002269_muscular_atrophy | 0.71088895 |
| 134 | MP0001944_abnormal_pancreas_morphology | 0.70947078 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.69866360 |
| 136 | MP0003011_delayed_dark_adaptation | 0.69693236 |
| 137 | MP0010094_abnormal_chromosome_stability | 0.66965022 |
| 138 | MP0009115_abnormal_fat_cell | 0.65547189 |
| 139 | MP0005647_abnormal_sex_gland | 0.65090110 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.62836787 |
| 141 | MP0002254_reproductive_system_inflammat | 0.62373976 |
| 142 | MP0003959_abnormal_lean_body | 0.62352488 |
| 143 | MP0009764_decreased_sensitivity_to | 0.61598406 |
| 144 | MP0005058_abnormal_lysosome_morphology | 0.61542612 |
| 145 | MP0000013_abnormal_adipose_tissue | 0.56976197 |
| 146 | MP0001661_extended_life_span | 0.56437242 |
| 147 | MP0000003_abnormal_adipose_tissue | 0.54578827 |
| 148 | MP0002928_abnormal_bile_duct | 0.49745688 |
| 149 | MP0004215_abnormal_myocardial_fiber | 0.49717146 |
| 150 | MP0009672_abnormal_birth_weight | 0.49049175 |
| 151 | MP0004036_abnormal_muscle_relaxation | 0.48927405 |
| 152 | MP0009765_abnormal_xenobiotic_induced | 0.48033109 |
| 153 | MP0005452_abnormal_adipose_tissue | 0.47781958 |
| 154 | MP0003300_gastrointestinal_ulcer | 0.46829062 |
| 155 | MP0005408_hypopigmentation | 0.46605764 |
| 156 | MP0000747_muscle_weakness | 0.46343755 |
| 157 | MP0003183_abnormal_peptide_metabolism | 0.46177948 |
| 158 | MP0000639_abnormal_adrenal_gland | 0.45526980 |
| 159 | MP0003221_abnormal_cardiomyocyte_apopto | 0.44364661 |
| 160 | MP0002822_catalepsy | 0.43955153 |
| 161 | MP0004147_increased_porphyrin_level | 0.43856156 |
| 162 | MP0008872_abnormal_physiological_respon | 0.41924993 |
| 163 | MP0004084_abnormal_cardiac_muscle | 0.41893381 |
| 164 | MP0004087_abnormal_muscle_fiber | 0.41348507 |
| 165 | MP0005385_cardiovascular_system_phenoty | 0.40680502 |
| 166 | MP0001544_abnormal_cardiovascular_syste | 0.40680502 |
| 167 | MP0002693_abnormal_pancreas_physiology | 0.39365952 |
| 168 | MP0003638_abnormal_response/metabolism_ | 0.38583815 |
| 169 | MP0008874_decreased_physiological_sensi | 0.38377296 |
| 170 | MP0000751_myopathy | 0.38011844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.82763519 |
| 2 | Hyperglycinuria (HP:0003108) | 5.30895045 |
| 3 | * Ketosis (HP:0001946) | 5.05409819 |
| 4 | Hypoglycemic coma (HP:0001325) | 5.01318716 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.99522831 |
| 6 | Xanthomatosis (HP:0000991) | 4.97189289 |
| 7 | Hyperammonemia (HP:0001987) | 4.88632626 |
| 8 | Deep venous thrombosis (HP:0002625) | 4.81608334 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.73843421 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 4.73843421 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.71142576 |
| 12 | Hyperglycinemia (HP:0002154) | 4.62869250 |
| 13 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.51456870 |
| 14 | * Ketoacidosis (HP:0001993) | 4.49926958 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.45755549 |
| 16 | Genetic anticipation (HP:0003743) | 4.20711703 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 4.20141001 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.07711907 |
| 19 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.93093990 |
| 20 | * Dicarboxylic aciduria (HP:0003215) | 3.92437396 |
| 21 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.92437396 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.89738851 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 3.87958653 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.87591943 |
| 25 | Prolonged partial thromboplastin time (HP:0003645) | 3.78683199 |
| 26 | Congenital stationary night blindness (HP:0007642) | 3.78546537 |
| 27 | Gout (HP:0001997) | 3.63431878 |
| 28 | Hypolipoproteinemia (HP:0010981) | 3.63348791 |
| 29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.60273136 |
| 30 | Generalized aminoaciduria (HP:0002909) | 3.51894917 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.50931001 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.50501407 |
| 33 | Attenuation of retinal blood vessels (HP:0007843) | 3.42984612 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 3.40282841 |
| 35 | Complement deficiency (HP:0004431) | 3.39493471 |
| 36 | Abnormality of B cell number (HP:0010975) | 3.36972721 |
| 37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.26859504 |
| 38 | Metabolic acidosis (HP:0001942) | 3.26437381 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 3.25442605 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 3.20720527 |
| 41 | Delayed CNS myelination (HP:0002188) | 3.20258878 |
| 42 | Recurrent fungal infections (HP:0002841) | 3.19832693 |
| 43 | Epidermoid cyst (HP:0200040) | 3.17071348 |
| 44 | Lethargy (HP:0001254) | 3.14878258 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 3.13350342 |
| 46 | Clumsiness (HP:0002312) | 3.10164791 |
| 47 | Myoglobinuria (HP:0002913) | 3.08029156 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 3.05847397 |
| 49 | Hypoglycemic seizures (HP:0002173) | 3.03353299 |
| 50 | Gaze-evoked nystagmus (HP:0000640) | 3.00609050 |
| 51 | Cerebral edema (HP:0002181) | 3.00587399 |
| 52 | Agammaglobulinemia (HP:0004432) | 3.00110148 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.97764122 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.97764122 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95080948 |
| 56 | Abnormality of the common coagulation pathway (HP:0010990) | 2.94810078 |
| 57 | Abnormality of methionine metabolism (HP:0010901) | 2.90789808 |
| 58 | Late onset (HP:0003584) | 2.89970316 |
| 59 | Progressive cerebellar ataxia (HP:0002073) | 2.87895167 |
| 60 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.84656117 |
| 61 | Proximal tubulopathy (HP:0000114) | 2.83207868 |
| 62 | Colitis (HP:0002583) | 2.82312406 |
| 63 | Hyperventilation (HP:0002883) | 2.81507688 |
| 64 | Hyperbilirubinemia (HP:0002904) | 2.81256285 |
| 65 | Fat malabsorption (HP:0002630) | 2.79916980 |
| 66 | Pustule (HP:0200039) | 2.78137815 |
| 67 | Joint hemorrhage (HP:0005261) | 2.74520560 |
| 68 | Abnormality of the intrinsic pathway (HP:0010989) | 2.74496116 |
| 69 | Severe visual impairment (HP:0001141) | 2.67718614 |
| 70 | Stomach cancer (HP:0012126) | 2.65576146 |
| 71 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.63959536 |
| 72 | * Vomiting (HP:0002013) | 2.63698764 |
| 73 | Hypercholesterolemia (HP:0003124) | 2.58754698 |
| 74 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.58542161 |
| 75 | Abnormality of T cell physiology (HP:0011840) | 2.58420544 |
| 76 | Hepatic necrosis (HP:0002605) | 2.57930563 |
| 77 | Increased purine levels (HP:0004368) | 2.54641158 |
| 78 | Hyperuricemia (HP:0002149) | 2.54641158 |
| 79 | Recurrent viral infections (HP:0004429) | 2.52978087 |
| 80 | IgG deficiency (HP:0004315) | 2.49919959 |
| 81 | Inflammation of the large intestine (HP:0002037) | 2.47914089 |
| 82 | Abnormality of T cells (HP:0002843) | 2.47526373 |
| 83 | Meningitis (HP:0001287) | 2.47448897 |
| 84 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.47336382 |
| 85 | Skin nodule (HP:0200036) | 2.46676718 |
| 86 | Abnormality of complement system (HP:0005339) | 2.45460539 |
| 87 | Severe combined immunodeficiency (HP:0004430) | 2.45053707 |
| 88 | Recurrent bacterial skin infections (HP:0005406) | 2.44633697 |
| 89 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.44252906 |
| 90 | Decreased circulating renin level (HP:0003351) | 2.44036246 |
| 91 | Neonatal onset (HP:0003623) | 2.42069689 |
| 92 | Decreased central vision (HP:0007663) | 2.40689996 |
| 93 | Autoimmune hemolytic anemia (HP:0001890) | 2.39572456 |
| 94 | Mediastinal lymphadenopathy (HP:0100721) | 2.38919238 |
| 95 | Rhabdomyolysis (HP:0003201) | 2.38577669 |
| 96 | Acute encephalopathy (HP:0006846) | 2.37918486 |
| 97 | Hydroxyprolinuria (HP:0003080) | 2.37815630 |
| 98 | Abnormality of proline metabolism (HP:0010907) | 2.37815630 |
| 99 | Hepatocellular carcinoma (HP:0001402) | 2.36892723 |
| 100 | Abnormality of the fingertips (HP:0001211) | 2.36763710 |
| 101 | Pancreatic cysts (HP:0001737) | 2.36657184 |
| 102 | Stomatitis (HP:0010280) | 2.36349219 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 2.36251111 |
| 104 | Thyroiditis (HP:0100646) | 2.33519937 |
| 105 | Hyperglycemia (HP:0003074) | 2.33034522 |
| 106 | Recurrent abscess formation (HP:0002722) | 2.32755858 |
| 107 | Symptomatic seizures (HP:0011145) | 2.32403428 |
| 108 | Conjugated hyperbilirubinemia (HP:0002908) | 2.31970395 |
| 109 | B lymphocytopenia (HP:0010976) | 2.29987057 |
| 110 | Abnormality of eosinophils (HP:0001879) | 2.28584146 |
| 111 | Irritability (HP:0000737) | 2.28459793 |
| 112 | Hypochromic anemia (HP:0001931) | 2.27924527 |
| 113 | Granulocytopenia (HP:0001913) | 2.27618994 |
| 114 | Abnormality of urine glucose concentration (HP:0011016) | 2.26826364 |
| 115 | Glycosuria (HP:0003076) | 2.26826364 |
| 116 | Eosinophilia (HP:0001880) | 2.25907035 |
| 117 | Brushfield spots (HP:0001088) | 2.24312465 |
| 118 | Pancreatitis (HP:0001733) | 2.24091343 |
| 119 | Abnormality of T cell number (HP:0011839) | 2.23937118 |
| 120 | Chronic diarrhea (HP:0002028) | 2.23846434 |
| 121 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.22486973 |
| 122 | Abnormality of DNA repair (HP:0003254) | 2.22397603 |
| 123 | Myositis (HP:0100614) | 2.22331196 |
| 124 | Acute lymphatic leukemia (HP:0006721) | 2.21938861 |
| 125 | Increased muscle lipid content (HP:0009058) | 2.20022929 |
| 126 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.19742730 |
| 127 | Cholelithiasis (HP:0001081) | 2.17321846 |
| 128 | Ragged-red muscle fibers (HP:0003200) | 2.16801436 |
| 129 | Vasculitis (HP:0002633) | 2.16684026 |
| 130 | Abnormal gallbladder morphology (HP:0012437) | 2.14695179 |
| 131 | Polydipsia (HP:0001959) | 2.14343251 |
| 132 | Abnormal drinking behavior (HP:0030082) | 2.14343251 |
| 133 | Spastic diplegia (HP:0001264) | 2.13528813 |
| 134 | Encephalitis (HP:0002383) | 2.11179281 |
| 135 | Nausea (HP:0002018) | 2.11153506 |
| 136 | Sensorimotor neuropathy (HP:0007141) | 2.09973434 |
| 137 | Malnutrition (HP:0004395) | 2.07938865 |
| 138 | Hypoplasia of the thymus (HP:0000778) | 2.07550183 |
| 139 | Recurrent skin infections (HP:0001581) | 2.06378880 |
| 140 | Alkalosis (HP:0001948) | 2.02618277 |
| 141 | Protruding tongue (HP:0010808) | 2.01652776 |
| 142 | Recurrent bronchitis (HP:0002837) | 2.01284161 |
| 143 | Abnormality of the renal cortex (HP:0011035) | 2.01076181 |
| 144 | Limb hypertonia (HP:0002509) | 2.00972356 |
| 145 | * Methylmalonic aciduria (HP:0012120) | 2.00484424 |
| 146 | Abnormal cartilage morphology (HP:0002763) | 2.00298215 |
| 147 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99757282 |
| 148 | Obstructive lung disease (HP:0006536) | 1.99757282 |
| 149 | Eczematoid dermatitis (HP:0000976) | 1.99531945 |
| 150 | Vascular calcification (HP:0004934) | 1.98267544 |
| 151 | Poikiloderma (HP:0001029) | 1.97989417 |
| 152 | Recurrent sinusitis (HP:0011108) | 1.97977344 |
| 153 | Leukocytosis (HP:0001974) | 1.97682900 |
| 154 | Abolished electroretinogram (ERG) (HP:0000550) | 1.97133236 |
| 155 | Lactic acidosis (HP:0003128) | 1.96610939 |
| 156 | Opisthotonus (HP:0002179) | 1.96427812 |
| 157 | Global brain atrophy (HP:0002283) | 1.96315590 |
| 158 | Chronic hepatic failure (HP:0100626) | 1.95793948 |
| 159 | Abnormal gallbladder physiology (HP:0012438) | 1.94514123 |
| 160 | Cholecystitis (HP:0001082) | 1.94514123 |
| 161 | T lymphocytopenia (HP:0005403) | 1.93758833 |
| 162 | Acute hepatic failure (HP:0006554) | 1.93346209 |
| 163 | Pendular nystagmus (HP:0012043) | 1.93282921 |
| 164 | IgA deficiency (HP:0002720) | 1.92919116 |
| 165 | Impaired smooth pursuit (HP:0007772) | 1.92873480 |
| 166 | Myocardial infarction (HP:0001658) | 1.91942121 |
| 167 | Death in childhood (HP:0003819) | 1.90707663 |
| 168 | Steatorrhea (HP:0002570) | 1.89291276 |
| 169 | Abnormality of binocular vision (HP:0011514) | 1.88560936 |
| 170 | Diplopia (HP:0000651) | 1.88560936 |
| 171 | Tachypnea (HP:0002789) | 1.88023190 |
| 172 | Pulmonary infiltrates (HP:0002113) | 1.87617738 |
| 173 | Hypertriglyceridemia (HP:0002155) | 1.86754603 |
| 174 | Insulin resistance (HP:0000855) | 1.86290398 |
| 175 | Prolonged bleeding time (HP:0003010) | 1.85852892 |
| 176 | Renal cortical cysts (HP:0000803) | 1.85508449 |
| 177 | Congenital sensorineural hearing impairment (HP:0008527) | 1.85308748 |
| 178 | Elevated hepatic transaminases (HP:0002910) | 1.82686031 |
| 179 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.82512026 |
| 180 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.82512026 |
| 181 | Tented upper lip vermilion (HP:0010804) | 1.81468636 |
| 182 | Hypoplasia of the pons (HP:0012110) | 1.81456363 |
| 183 | Abnormality of the prostate (HP:0008775) | 1.81134319 |
| 184 | Lymphopenia (HP:0001888) | 1.80620622 |
| 185 | Prominent nose (HP:0000448) | 1.80592256 |
| 186 | Abnormality of the renal collecting system (HP:0004742) | 1.80228385 |
| 187 | Abnormality of the columella (HP:0009929) | 1.80090671 |
| 188 | Large for gestational age (HP:0001520) | 1.79118102 |
| 189 | Esophageal varix (HP:0002040) | 1.77158832 |
| 190 | IgM deficiency (HP:0002850) | 1.76904614 |
| 191 | Albinism (HP:0001022) | 1.75919912 |
| 192 | Gastrointestinal infarctions (HP:0005244) | 1.75849690 |
| 193 | Combined immunodeficiency (HP:0005387) | 1.74653424 |
| 194 | Visual hallucinations (HP:0002367) | 1.73876023 |
| 195 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.73791302 |
| 196 | Cystic liver disease (HP:0006706) | 1.73320937 |
| 197 | Prostate neoplasm (HP:0100787) | 1.73242040 |
| 198 | Patellar aplasia (HP:0006443) | 1.72638699 |
| 199 | Duplicated collecting system (HP:0000081) | 1.70722730 |
| 200 | Abnormality of midbrain morphology (HP:0002418) | 1.67990251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.04920436 |
| 2 | FRK | 5.74311286 |
| 3 | TRIB3 | 4.48369339 |
| 4 | ERN1 | 3.80169292 |
| 5 | SIK1 | 3.49788159 |
| 6 | FGFR4 | 3.18332326 |
| 7 | WNK3 | 3.13484254 |
| 8 | PDK3 | 2.90891358 |
| 9 | PDK4 | 2.90891358 |
| 10 | PKN2 | 2.72167995 |
| 11 | INSRR | 2.62412426 |
| 12 | TNK2 | 2.42104686 |
| 13 | FLT3 | 2.33289525 |
| 14 | ADRBK2 | 2.21343094 |
| 15 | NEK1 | 2.19989833 |
| 16 | TXK | 2.02216268 |
| 17 | BLK | 1.90088797 |
| 18 | TLK1 | 1.88666018 |
| 19 | MAP3K10 | 1.85280965 |
| 20 | RIPK4 | 1.78249308 |
| 21 | SIK2 | 1.75847136 |
| 22 | SYK | 1.68916999 |
| 23 | FES | 1.60566127 |
| 24 | IKBKB | 1.58667891 |
| 25 | WNK4 | 1.52676685 |
| 26 | TEC | 1.52603855 |
| 27 | BMPR1B | 1.52039889 |
| 28 | MAPK11 | 1.46189182 |
| 29 | MAPK15 | 1.41580780 |
| 30 | PTK6 | 1.38840826 |
| 31 | ZAK | 1.38014929 |
| 32 | ITK | 1.34350697 |
| 33 | IRAK4 | 1.30598892 |
| 34 | LMTK2 | 1.26588336 |
| 35 | EEF2K | 1.23776954 |
| 36 | PDK2 | 1.21268087 |
| 37 | PINK1 | 1.20913824 |
| 38 | IKBKE | 1.19400526 |
| 39 | CDK12 | 1.18599113 |
| 40 | GRK6 | 1.14107579 |
| 41 | MAP2K4 | 1.11405830 |
| 42 | MST1R | 1.11035352 |
| 43 | GRK1 | 1.09831738 |
| 44 | MAP3K7 | 1.08898441 |
| 45 | MARK3 | 1.05166516 |
| 46 | DAPK2 | 1.04271026 |
| 47 | MAP3K11 | 1.02458661 |
| 48 | MAP4K1 | 1.00124391 |
| 49 | LYN | 1.00101708 |
| 50 | PRKAA2 | 1.00069486 |
| 51 | HCK | 0.99692846 |
| 52 | CAMK1D | 0.98615673 |
| 53 | PRKD2 | 0.98346732 |
| 54 | LCK | 0.97315066 |
| 55 | RIPK1 | 0.93615526 |
| 56 | KDR | 0.93514768 |
| 57 | MAP3K14 | 0.93416308 |
| 58 | CAMKK2 | 0.91837909 |
| 59 | PRKAA1 | 0.91633849 |
| 60 | TTN | 0.91576766 |
| 61 | TYK2 | 0.90574547 |
| 62 | TIE1 | 0.90427229 |
| 63 | CAMKK1 | 0.85860324 |
| 64 | PRKCQ | 0.85133370 |
| 65 | NUAK1 | 0.83987821 |
| 66 | PTK2B | 0.83965864 |
| 67 | DYRK1B | 0.83207339 |
| 68 | MAP3K13 | 0.82602893 |
| 69 | JAK2 | 0.82118096 |
| 70 | PHKG2 | 0.79646678 |
| 71 | PHKG1 | 0.79646678 |
| 72 | MAPK13 | 0.79434731 |
| 73 | RPS6KA6 | 0.76735003 |
| 74 | CHUK | 0.74347650 |
| 75 | SGK3 | 0.73840473 |
| 76 | CDK4 | 0.73095563 |
| 77 | NLK | 0.73010671 |
| 78 | CDC42BPA | 0.72822042 |
| 79 | MAP2K3 | 0.72086362 |
| 80 | MYLK | 0.71705891 |
| 81 | TBK1 | 0.71674505 |
| 82 | SCYL2 | 0.70573005 |
| 83 | MARK2 | 0.69095571 |
| 84 | STK38L | 0.68971311 |
| 85 | MAPKAPK3 | 0.68754355 |
| 86 | LATS1 | 0.68746766 |
| 87 | TAOK3 | 0.68013821 |
| 88 | PIM1 | 0.67864430 |
| 89 | ADRBK1 | 0.67136225 |
| 90 | ICK | 0.65823710 |
| 91 | HIPK2 | 0.65750341 |
| 92 | MELK | 0.63687098 |
| 93 | ACVR1B | 0.63299003 |
| 94 | PIK3CG | 0.62670995 |
| 95 | PDPK1 | 0.61798661 |
| 96 | CCNB1 | 0.61739729 |
| 97 | MAP3K3 | 0.60713756 |
| 98 | MAP2K6 | 0.59641066 |
| 99 | TGFBR1 | 0.59409901 |
| 100 | PRKACG | 0.57183435 |
| 101 | TRPM7 | 0.56566174 |
| 102 | CAMK1 | 0.55098718 |
| 103 | PDGFRA | 0.54944302 |
| 104 | PRKCZ | 0.54277797 |
| 105 | CSK | 0.53823186 |
| 106 | PRKD3 | 0.53763035 |
| 107 | ERBB4 | 0.53750468 |
| 108 | RPS6KC1 | 0.53732823 |
| 109 | RPS6KL1 | 0.53732823 |
| 110 | JAK1 | 0.52916632 |
| 111 | MAP2K1 | 0.52827765 |
| 112 | PDK1 | 0.51748432 |
| 113 | MTOR | 0.51409740 |
| 114 | MAP4K2 | 0.51097136 |
| 115 | FGFR3 | 0.49371602 |
| 116 | PASK | 0.47928142 |
| 117 | MAP2K2 | 0.47170532 |
| 118 | KIT | 0.47026929 |
| 119 | LRRK2 | 0.46543373 |
| 120 | CSF1R | 0.45876586 |
| 121 | NEK2 | 0.45741029 |
| 122 | CAMK4 | 0.45622287 |
| 123 | MAPK4 | 0.45291794 |
| 124 | MAPK3 | 0.44800229 |
| 125 | AKT2 | 0.44772758 |
| 126 | RPS6KA5 | 0.44106259 |
| 127 | CAMK1G | 0.43679779 |
| 128 | ATR | 0.43100699 |
| 129 | PRKCH | 0.43069522 |
| 130 | MAPK7 | 0.42796571 |
| 131 | MAPK12 | 0.41973109 |
| 132 | SGK494 | 0.41054812 |
| 133 | SGK223 | 0.41054812 |
| 134 | OXSR1 | 0.40602435 |
| 135 | ERBB2 | 0.40562951 |
| 136 | RET | 0.40506882 |
| 137 | STK38 | 0.39424549 |
| 138 | ABL2 | 0.39004150 |
| 139 | GSK3A | 0.38363733 |
| 140 | ILK | 0.37761076 |
| 141 | MAP3K1 | 0.37674688 |
| 142 | EPHA3 | 0.36292918 |
| 143 | PTK2 | 0.36123911 |
| 144 | SGK2 | 0.35941090 |
| 145 | STK11 | 0.35875946 |
| 146 | MAP3K2 | 0.35764183 |
| 147 | MAPK8 | 0.32878726 |
| 148 | EPHB1 | 0.32591993 |
| 149 | PRKD1 | 0.30075396 |
| 150 | NEK9 | 0.29935934 |
| 151 | JAK3 | 0.28271602 |
| 152 | ZAP70 | 0.27987500 |
| 153 | IRAK1 | 0.27481656 |
| 154 | BTK | 0.27098120 |
| 155 | CDK6 | 0.27082945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.48436498 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.34157763 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.29765062 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.18760500 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.15121419 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.04261330 |
| 7 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.04167961 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.99049249 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.91545921 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.79897679 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.74527461 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.71847469 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.59506141 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.58076263 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55167228 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51645519 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.50109095 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.48315658 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44214578 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.39101894 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.33077865 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.15529542 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.14496879 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.11386724 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 2.08798886 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.05522999 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98583853 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.97688561 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.94409545 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85692659 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81396113 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77700482 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62527782 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62340634 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.61731582 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56556665 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.56216403 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54619701 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.54440158 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50998816 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50920791 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 1.49617940 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48601824 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 1.47061215 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.46759057 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.42687773 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41198278 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.40074439 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.38896870 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38688996 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.37832572 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.37172904 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.36826528 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.36463297 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.35644071 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35615749 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33952801 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33194767 |
| 59 | Homologous recombination_Homo sapiens_hsa03440 | 1.30729566 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30615329 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29428061 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28950237 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27125953 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26234964 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.25556402 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.24604387 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22027534 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.21523582 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20431481 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15149858 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14693037 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12563867 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11053864 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.10287519 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 1.06968993 |
| 76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05766788 |
| 77 | Tuberculosis_Homo sapiens_hsa05152 | 1.03729279 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01827409 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01654040 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01313590 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99658707 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.98083101 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96757812 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.96590994 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96429359 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93888721 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93250799 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93250771 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92353726 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90576683 |
| 91 | Taste transduction_Homo sapiens_hsa04742 | 0.90454920 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89458458 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.86550011 |
| 94 | Influenza A_Homo sapiens_hsa05164 | 0.84162709 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81604435 |
| 96 | Measles_Homo sapiens_hsa05162 | 0.81492194 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80306750 |
| 98 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79538907 |
| 99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79140385 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76875751 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75670771 |
| 102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75602944 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73230578 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72703408 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72478568 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71102390 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67573073 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.67025371 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66393468 |
| 110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65255433 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62849804 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62428082 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62205846 |
| 114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62130827 |
| 115 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61970387 |
| 116 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61574488 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.61264119 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60919538 |
| 119 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59657094 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.56884128 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56618032 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.56121251 |
| 123 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55433750 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54005270 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53756664 |
| 126 | Morphine addiction_Homo sapiens_hsa05032 | 0.53285386 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.53188642 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53046340 |
| 129 | RNA polymerase_Homo sapiens_hsa03020 | 0.53033548 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52635384 |
| 131 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51612680 |
| 132 | Salivary secretion_Homo sapiens_hsa04970 | 0.51517715 |
| 133 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49278579 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48078484 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47404357 |
| 136 | Hepatitis B_Homo sapiens_hsa05161 | 0.46867552 |
| 137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46467636 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41208303 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40580776 |
| 140 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40132219 |
| 141 | Parkinsons disease_Homo sapiens_hsa05012 | 0.36572505 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35273740 |
| 143 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33164525 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23361720 |
| 145 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.22959349 |
| 146 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.21960236 |
| 147 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17355169 |
| 148 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.14061551 |
| 149 | Alzheimers disease_Homo sapiens_hsa05010 | 0.12987143 |
| 150 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.09614615 |
| 151 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.09585575 |
| 152 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.08203789 |
| 153 | Prion diseases_Homo sapiens_hsa05020 | 0.05873273 |
| 154 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.03932034 |
| 155 | Huntingtons disease_Homo sapiens_hsa05016 | 0.01175934 |
| 156 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00868141 |
| 157 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -2.9855770 |
| 158 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1023752 |
| 159 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0983350 |
| 160 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0708565 |
| 161 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0600333 |
| 162 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0481945 |
| 163 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0432428 |
| 164 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0329943 |
| 165 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0175469 |
| 166 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0132522 |
| 167 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0084990 |
| 168 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0082934 |

